| 1 |
Torres A, Cilloniz C, Niederman MS, et al. Pneumonia[J]. Nat Rev Dis Primers, 2021, 7(1): 25.
|
| 2 |
熊 静，唐 睿，吴红梅. 重症肺炎患者肺康复治疗的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(4): 557-559.
|
| 3 |
Bian LQ, Bi Y, Zhou SW, et al. T cell responses in senior patients with community-acquired pneumonia related to disease severity [J]. Exp Cell Res, 2017, 361(1): 56-62.
|
| 4 |
Akbari H, Tabrizi R, Lankarani KB, et al. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis[J]. Life Sci, 2020, 258: 118167.
|
| 5 |
Kared H, Camous X, Larbi A. T cells and their cytokines in persistent stimulation of the immune system [J]. Curr Opin Immunol, 2014, 29: 79-85.
|
| 6 |
Saravia J, Chapman NM, Chi H. Helper T cell differentiation [J]. Cell Mol Immunol, 2019, 16(7): 634-643.
|
| 7 |
Zhao C, Wang D, Wu M, et al. Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression [J]. J Int Med Res, 2020, 48(6): 300060520926011.
|
| 8 |
郑丽丽，许航燕，应旦红. 重症腺病毒肺炎患儿T细胞亚群变化及其临床意义的研究[J]. 浙江医学，2018, 40(15): 1702-1704.
|
| 9 |
葛蓓蕾. 血必净联合肺泡灌洗吸痰对重症肺炎血清T淋巴细胞亚群的影响[J]. 深圳中西医结合杂志，2021, 31(6): 46-47.
|
| 10 |
王红梅，黄丽蓉. 重症肺炎患者细胞免疫功能研究[J]. 新乡医学院学报，2011, 28(6): 749-751.
|
| 11 |
吴 强，卢春晓，肖 强，等. 危重型新型冠状病毒肺炎患者T淋巴细胞亚群分析[J]. 暨南大学学报(自然科学与医学版), 2021, 42(1): 80-87.
|
| 12 |
Xin LH, Wang J, Wang Z, et al. Effect of Mycoplasma pneumoniae infection on function of T lymphocytes in bronchoalveolar lavage fluid of asthmatic children[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2014, 16(3): 277-280.
|
| 13 |
王丹丹，王蕴娴. CD3+、CD4+、CD8+ T淋巴细胞预测难治性肺炎支原体肺炎患儿塑型性支气管炎的价值及意义[J]. 国际检验医学杂志，2022, 43(12): 1440-1443.
|
| 14 |
沈 阳，边兴艳，李 季，等. 儿童肺炎支原体肺炎外周血T淋巴细胞亚群与细胞因子以及免疫球蛋白的动态探析[J]. 当代医学，2022, 28(5): 77-80.
|
| 15 |
王 凡，陈旭昕，韩志海. 重症肺炎早期患者外周血T淋巴细胞亚群比例变化及预后预测效能[J]. 山东医药，2021, 61(27): 32-36.
|
| 16 |
李 菁，包 军，鲍一笑，等. 肺炎支原体肺炎患儿肺泡灌洗液病菌量及其与Th1/Th2细胞免疫应答的关系[J]. 临床儿科杂志，2015, 33(8): 681-685.
|
| 17 |
安 阳，王 莉，张俊迪，等. 多重耐药菌感染肺炎老年患者外周血中微RNA-127-5p水平与辅助性T细胞和调节性T细胞及其细胞因子的相关性[J]. 新乡医学院学报，2021, 38(11): 1053-1056.
|
| 18 |
时建秋. 孟鲁司特钠对肺炎患儿Th1、Th2细胞亚群的影响分析[J]. 四川解剖学杂志，2020, 28(3): 104-105.
|
| 19 |
范 慧，索 涛，苏梦茹，等. 感染源性急性呼吸窘迫综合征患者血Th1和Th2细胞及相关细胞因子检测的临床意义[J]. 临床肺科杂志，2021, 26(8): 1189-1192.
|
| 20 |
张添威，郭微微，张蓉映，等. 动态监测血清CRP对指导重症肺炎患者临床用药的意义及联合IL-8、Th1对预后预警的价值[J]. 广东医学，2021, 42(3): 283-287.
|
| 21 |
Caldrer S, Mazzi C, Bernardi M, et al. Regulatory T cells as predictors of clinical course in hospitalised COVID-19 patients [J]. Front Immunol, 2021, 12: 789735.
|
| 22 |
Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China[J]. Clin Infect Dis, 2020, 71(15): 762-768.
|
| 23 |
Paats MS, Bergen IM, Hanselaar WEJJ, et al. T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia[J]. Thorax, 2013, 68(5): 468-474.
|
| 24 |
Pandiyan P, Bhaskaran N, Zou M, et al. Microbiome dependent regulation of T and Th17 cells in mucosa[J]. Front Immunol, 2019, 10: 426.
|
| 25 |
Lu B, Liu M, Wang J, et al. IL-17 production by tissue-resident MAIT cells is locally induced in children with pneumonia[J]. Mucosal Immunol, 2020, 13(5): 824-835.
|
| 26 |
毛玉林，陆珠凤，黄俊峰，等. 黏膜相关恒定T细胞水平在脓毒症患者中的临床意义[J]．中国感染与化疗杂志，2017, 17(4): 376-381.
|
| 27 |
Muyayalo KP, Huang DH, Zhao SJ, et al. COVID-19 and Treg/Th17 imbalance: potential relationship to pregnancy outcomes[J]. Am J Reprod Immunol, 2020, 84(5): e13304.
|
| 28 |
Durant LR, Makris S, Voorburg CM, et al. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice[J]. J Virol, 2013, 87(20): 10946-10954.
|
| 29 |
Wan Z, Zhou Z, Liu Y, et al. Regulatory T cells and T helper 17 cells in viral infection[J]. Scand J Immunol, 2020, 91(5): e12873.
|
| 30 |
Karki R, Kanneganti TD. The 'cytokine storm’：molecular mechanisms and therapeutic prospects[J]. Trends Immunol, 2021, 42(8): 681-705.
|
| 31 |
康妍萌，丁明杰，韩玉玲，等. 重症肺炎支原体肺炎患儿肺泡灌洗液中Th1/Th2细胞免疫应答状况的研究[J]．中国当代儿科杂志，2011, 13(3): 188-190.
|
| 32 |
Zhang Y, Mei S, Zhou Y, et al. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children[J]. Sci Rep, 2016, 6: 37037.
|
| 33 |
Jin HL, Zhan L, Mei SF, et al. Serum cytokines and FeNO in school-aged children with mycoplasma pneumoniae pneumonia[J]. Med Sci Monit, 2020, 26: e923449.
|
| 34 |
Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors[J]. Emerg Microbes Infect, 2020, 9(1): 1123-1130.
|
| 35 |
Guo Y, Hu K, LI Y, et al. Targeting TNF-α for COVID-19: recent advanced and controversies[J]. Front Public Health, 2022, 10: 833967.
|
| 36 |
方昌全，徐丽敏，邹 丽，等. 重症肺炎患者Th17及Treg相关细胞因子的动态变化[J]. 临床肺科杂志，2022, 27(5): 665-667.
|
| 37 |
卢惠丹，李 颖，胡春玲，等. 重症肺炎患者IL-6/IL-10的平衡与预后的相关性分析[J]. 河南医学研究，2019, 28(5): 783-785.
|
| 38 |
Warren RB, BlauveltL A, Bagel J, et al. Bimekizumab versus adalimumab in plaque psoriasis[J]. N Engl J Med, 2021, 385(2): 130-141.
|
| 39 |
Fan H, Lu B, Yang D, et al. Distribution and expression of IL-17 and related cytokines in children with Mycoplasma pneumoniae Pneumonia[J]. Jpn J Infect Dis, 2019, 72(6): 387-393.
|
| 40 |
Liu M, Lu B, Fan H, et al. Heightened local T17 cell inflammation is associated with severe community-acquired pneumonia in children under the age of 1 year[J]. Mediators Inflamm, 2021. doi: 10.1155/2021/9955168.
|
| 41 |
Haugen J, Chandyo RK, Brokstad KA, et al. Cytokine concentrations in plasma from children with severe and non-severe community acquired pneumonia[J]. PLoS One, 2015, 10(9): e0138978.
|
| 42 |
Bonaventura A, Vecchié A, Wang TS, et al. Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies [J]. Front Immunol, 2020, 11: 1625.
|
| 43 |
Gao M, Liu LX, Wu FL, et al. The changes of Th17/Treg and related cytokines: IL-17, IL-23, IL-10, and TGF-β in respiratory syncytial virus bronchiolitis rat Model[J]. Iran J Allergy Asthma Immunol, 2017, 16(5): 386-395.
|
| 44 |
邹映雪，张旭冉. 儿童重症肺炎生物标志物研究及应用进展[J]. 中国实用儿科杂志，2022, 37(2): 92-96.
|
| 45 |
吴 晗，刘晨玢，毛胤祺，等. 流式细胞分析仪检测细胞因子方法学性能验证[J]. 检验医学与临床，2021, 18(10): 1345-1349.
|